Contemporary OB/GYN

Contemporary OB/GYN Expert advice for today’s ob-gyn.

06/08/2026

Jennifer Hoskovec, MS, CGC, explains the Unity Confirm, a non-invasive confirmation test that utilizes circulating fetal cells to verify high-risk prenatal screening results.

Watch the full interview and learn more about the launch of Unity Confirm, which was announced at the 2026 American College of Obstetricians & Gynecologists (ACOG) Annual Clinical & Scientific Meeting.

Click here for the full clip: https://hubs.li/Q04jRbt50

06/07/2026

Sunday Spotlight:

Using deep plasma proteomics rather than circulating tumor DNA, Certitude Breast addresses a known early-detection gap for breast cancer, particularly in women with dense breast tissue.

Justin Drake, PhD, Chief Science Officer, Astrin Biosciences, and Associate Professor at the University of Minnesota, joined us to discuss Astrin’s Certitude Breast, a blood-based test for early breast cancer detection.

Watch the full interview here: https://hubs.li/Q04k82Cw0

In our Article of the Week:Nearly 18 million US-women aged 45 to 64 are overdue for at least 1 recommended cancer screen...
06/06/2026

In our Article of the Week:

Nearly 18 million US-women aged 45 to 64 are overdue for at least 1 recommended cancer screening, with approximately 7.6 million behind on multiple tests simultaneously.

See the full breakdown: https://hubs.li/Q04k88Tm0

In our latest expert interview, Susan Loeb-Zeitlin, MD, FACOG, of Weill Cornell Medicine, joined us to discuss 's recen...
06/04/2026

In our latest expert interview, Susan Loeb-Zeitlin, MD, FACOG, of Weill Cornell Medicine, joined us to discuss 's recently updated clinical guidelines on postmenopausal bleeding.

WATCH: https://hubs.li/Q04k6cLV0

06/04/2026

Thank you, Hugh Taylor, MD, of Yale Medicine, for explaining how a blood-based test could lead to earlier diagnosis and care of .

Watch the full discussion and learn more about the findings recently published in Biomarker Research here: https://hubs.li/Q04jQtfb0

Nearly 18 million US-women aged 45 to 64 are overdue for at least 1 recommended cancer screening, with approximately 7.6...
06/03/2026

Nearly 18 million US-women aged 45 to 64 are overdue for at least 1 recommended cancer screening, with approximately 7.6 million behind on multiple tests simultaneously.

See the full breakdown: https://hubs.li/Q04jZ9dd0

06/03/2026

Sameena Rahman, MD, FACOG, shared why the shift to Polyendocrine Metabolic Ovarian Syndrome is a "huge move" for patient care. By moving beyond "GYN terminology" and focusing on systemic metabolic health, clinicians can better prevent long-term cardiovascular issues and end the cycle of patient dismissal.

Additionally, Rahman stated that treating the condition should involve all aspects of care from any clinicians who treat women.

Watch the full interview by clicking here: https://hubs.li/Q04jQ8bZ0

06/02/2026

Thank you, Melissa Loseke Ablett, DO, of Joi+Blokes, for speaking with us about a recent study published in Journal of Personalized Medicine, which found that TRT "was associated with broad symptomatic improvement spanning energy/fatigue, depression, irritability, anhedonia, cognitive function, and sexual interest," according to study authors.

Watch the full interview and get a breakdown of the data and TRT's association with improved symptom burden: https://hubs.li/Q04jP_ZC0

ICYMI: The has approved cefepime and zidebactam (ZAYNICH; Wockhardt Ltd.), a novel intravenous antibiotic targeting ad...
06/02/2026

ICYMI:

The has approved cefepime and zidebactam (ZAYNICH; Wockhardt Ltd.), a novel intravenous antibiotic targeting adults with complicated urinary tract infections (cUTI), including pyelonephritis. The therapy targets multiple penicillin-binding proteins simultaneously to overcome resistant Gram-negative bacteria. Learn more about the ENHANCE-1 trial data.

Full approval details as well as trial data can be found here: https://hubs.li/Q04jMD8x0

The Society for Maternal-Fetal Medicine has released an updated statement in the SMFM Pregnancy Journal reaffirming the ...
06/01/2026

The Society for Maternal-Fetal Medicine has released an updated statement in the SMFM Pregnancy Journal reaffirming the safety of during . A comprehensive data review shows no causal link between the medication and childhood autism or .

More on the latest reaffirmation for acetaminophen: https://hubs.li/Q04jFZvZ0

Address

25115 Country Club Boulevard
North Olmsted, OH
44070

Website

Alerts

Be the first to know and let us send you an email when Contemporary OB/GYN posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category